A Phase 2 Single-Arm Study to Evaluate the Efficacy of Isatuximab, Pomalidomide and Low-Dose Dexamethasone, in Patients with AL Amyloidosis Not in VGPR or Better after Any Previous Therapy (IsAMYP)
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 12618-12620
10.1182/blood-2022-166337